// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Is there a mortality disadvantage in tracheobronchomalacia?

Nneka Nwosu - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

The clinical significance nocturnal hypoventilation (NH in patients with severe obstructive sleep apnoea (OSA

Shirley Coelho - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Sleep apnoea

N/A

How effective is Adaptive Servo Ventilation?

Elliott Dewsbury - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Sleep apnoea

Opiate

The effect of CPAP withdrawal on urinary androgen metabolites

Christopher Turnbull - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Androgen Tear

Overlap of OSA and Obstructive Airways Disease in Indian population: Does treating the underlying airflow obstruction improve OSA control?

Tarang Kulkarni - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Variability of OSA severity classification between two multiple-night sleep studies

Charlotte Wigston - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Performance of STOP-BANG questionnaire in bariatric surgical patients

Peter Cho - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Adherence to Continuous Positive Airways Pressure (CPAP in mild obstructive sleep apnoea (OSA

Shirley Coelho - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Sleep apnoea

N/A

The role of complement factor H and clusterin in obstructive sleep apnoea

Andras Bikov - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Sleep apnoea

N/A

Outcome of Mandibular Advancement Device (MAD referrals following a clinician led dental assessment in patients with Obstructive Sleep Apnoea Syndrome (OSAS

Amanda Witton - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Sleep apnoea

N/A

Factors associated with OSA in pre-operative bariatric patients

Peter Siu Pan Cho - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Screening for obesity hypoventilation syndrome in bariatric patients

Kieran Palmer - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Obesity hypoventilation syndrome

N/A

Late Breaking Abstract - An updated meta-analysis of uniportal versus multiportal video-assisted thoracoscopic lobectomy for lung cancer

Dimitrios Magouliotis - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Lung Cancer

N/A

Quality of life evolution in the first year after VATS lung resection and SABR for early stage NSCLC: a single centre analysis

Cecilia Pompili - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Non Small Cell Lung cancer

N/A

Eligibility for Lung Volume Reduction in patients with COPD attending Pulmonary Rehabilitation

Sara Buttery - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Lung volume reduction surgery - an underutilised treatment?

Sayed Alderazi - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Treatment complication rates in continued smokers vs quitters after a diagnosis of lung cancer: a cohort study

Kirsty Lanyon - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Non Small Cell Lung cancer

N/A

Smoking cessation in secondary care: Can we do better or is this as good as it gets?

Nitika Kaushal - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Participation in a targeted lung health check program and smoking cessation

Rebecca Mweseli - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Changes in performance status in continued smokers vs quitters after a diagnosis of lung cancer: a cohort study

Kirsty Lanyon - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Non Small Cell Lung cancer

N/A

Copyright © 2026. QuantiNova All rights reserved